drugset / Trial / NCT07081022
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the preliminary efficacy of JS203 combined with standard regimens in patients with B-cell Non-Hodgkin's lymphoma
Timeline
- Start
- 2025-08-17
- Primary completion
- 2027-04-06
- Completion
- 2027-04-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JS203 | Unknown | — | — |
| Background | Carboplatin | Small molecule | — | — |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Doxorubicin | Other / unclassified | — | — |
| Background | Etoposide | Small molecule | — | — |
| Background | Gemcitabine | Small molecule | — | — |
| Background | Ifosfamide | Small molecule | — | — |
| Background | Lenalidomide | Other / unclassified | — | — |
| Background | Oxaliplatin | Small molecule | — | — |
| Background | Prednisone | Other / unclassified | — | — |
| Background | Rituximab | Monoclonal antibody | — | — |
| Background | Vincristine | Small molecule | — | — |